FDA approves the new COVID-19 of modern doses

FDA approves the new COVID-19 of modern doses

The United States approved a new COVID-19 vaccine made by modern on Friday night but but With limits On who can use it, not a replacement for the company’s existing take, but a second option.

The new vaccine, MNEXSPike, is a passage to the next -generation coronavirus vaccines. It is made in a way that allows a lower dose, a fifth of the dose of its current COVID-19, spikevax, refining its immune target.

The approval “adds a new important tool to help protect people with a high risk of serious illness of COVID-19,” said Stephane Banll, Modern CEO, in a statement on Saturday.

The food and medication administration approved the new vaccine for use in all adults 65 years of age or older, and for people aged 12 to 64 who have at least a health condition that puts them at a higher risk of the coronavirus.

That is the same limit as the FDA established on another COVID-19 vaccine option of the competitor Novávax.

These restrictions are a deviation of how the United States has managed COVID-19 vaccines so far, reflecting skepticism about vaccines of Health Secretary Robert F. Kennedy Jr. and other Trump officials.

The existing modern vaccine does not face these limits and has been used for a long time for any person of 6 months or more. The company said it hoped to offer both options this fall.

The approval of the FDA was based on a study of 11,400 people over 12 years old that compared the new dose low vaccine with the existing modern vaccine. He found that the new vaccine was safe and at least it was so effective, and more for some measures, than the original take, the company said.

See also  The case of the defendants in Georgia 'Cop City' says that they are in Limbo as the delays in the trial continue

The news came only days after the Trump administration Canceled financing For Modern to develop a vaccine against potential pandemic flu viruses, including H5N1 aviar flu, despite the promising promising results of the study.

___

The Department of Health and Sciences of Associated Press receives support from the Science and Educational Media Group of the Howard Hughes Medical Institute and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Leave a Reply

Your email address will not be published. Required fields are marked *

nine + five =

Top